Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2024

Dec 10, 2024

34576_dirs_2024-12-09_f2cfd283-cbc7-4fa5-ac76-3e52d1c5fcd5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2024-12-06

Reporting Person: Chung Christine (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-12-06 Common Stock F 2792 $0.3421 Disposed 301552 Direct

Footnotes

F1: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of restricted stock units.